{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:10:34Z","timestamp":1787062234336,"version":"build-2736575974"},"reference-count":61,"publisher":"Georg Thieme Verlag KG","issue":"04","license":[{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Avicenna J Med"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mucormycosis (also known as black fungus) is caused by fungi of the Zygomycetes class and is the third most common invasive mycosis after candidiasis and aspergillosis. They colonize a large number of patients without invading them. Systemic glucocorticoids are currently used to treat severe Coronavirus disease 19 (COVID-19). In such patients, opportunistic fungal infections are a problem. Although COVID-19-related pulmonary aspergillosis is becoming more common, mucormycosis is still uncommon. Mucormycosis normally appears 10 to 14 days after being admitted to the hospital. Mucormycosis is a rare but dangerous infection that can make extreme COVID-19 worse.<\/jats:p>\n                  <jats:p>Mucormycosis is more likely to occur in people who have diabetes mellitus and other risk factors. Mucormycosis is most likely exacerbated by concurrent glucocorticoid treatment. To improve outcomes, a high index of suspicion and aggressive management is required. Excessive usage of steroids, monoclonal antibodies, and broad-spectrum antibiotics might cause the formation or worsen of a fungal infection.<\/jats:p>\n                  <jats:p>A high index of suspicion and aggressive management are needed. In patients with COVID-19 infection, physicians should be vigilant of the likelihood of subsequent invasive fungal infections. To enhance results in pulmonary mucormycosis, early diagnosis and treatment are critical. Confirmation of the clinical form necessitates a combination of symptoms that are consistent with tissue invasion histologically. Combining various clinical data and the isolation of the fungus from clinical samples in culture is needed for the probable diagnosis of mucormycosis. The organism that causes mucormycosis is identified using macroscopic and microscopic morphological criteria, carbohydrate assimilation, and the maximum temperature at which they can expand. Mucormycosis must be treated with antifungal medication prescribed by a doctor. It may necessitate surgery in some circumstances, and it can result in the loss of the upper jaw and, in some situations, an eye.<\/jats:p>","DOI":"10.1055\/s-0041-1735383","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T19:13:07Z","timestamp":1638472387000},"page":"210-216","source":"Crossref","is-referenced-by-count":7,"title":["COVID-19-Associated Mucormycosis, A New Incident in Recent Time: Is An Emerging Disease in The Near Future Impending?"],"prefix":"10.1055","volume":"11","author":[{"given":"Suman Kumar","family":"Ray","sequence":"additional","affiliation":[{"name":"Department of Applied Sciences, Indira Gandhi Technological and Medical Sciences University, Arunachal Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhes","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,12,2]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.idc.2021.03.009","article-title":"Mucormycosis","volume":"35","author":"J M Steinbrink","year":"2021","journal-title":"Infect Dis Clin North Am"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"M Ackermann","year":"2020","journal-title":"N Engl J Med"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/alr.22785","article-title":"Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19)","volume":"11","author":"M Karimi-Galougahi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.jinf.2020.02.029","article-title":"Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection","volume":"80","author":"J F Bermejo-Martin","year":"2020","journal-title":"J Infect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13319","article-title":"Diagnostic performance of real-time polymerase chain reaction assay on blood for invasive aspergillosis and mucormycosis","author":"H Seo","year":"2021","journal-title":"Mycoses"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"J A Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"S 07","key":"ref8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2006.01604.x","article-title":"Mucormycosis: an emerging disease?","volume":"12","author":"E Bouza","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14740\/jmc3637","article-title":"Rhinocerebral mucormycosis and COVID-19 pneumonia","volume":"12","author":"K Alekseyev","year":"2021","journal-title":"J Med Cases"},{"issue":"18","key":"ref10","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1056\/NEJMicm2030205","article-title":"Pulmonary Mucormycosis","volume":"384","author":"L Mejia Buritica","year":"2021","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000002181","article-title":"Pulmonary actinomycosis and mucormycosis coinfection in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia undergoing chemotherapy","author":"T Fujisaki","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"S 01","key":"ref12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1470-9465.2004.00843.x","article-title":"Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment","volume":"10","author":"R M Prabhu","year":"2004","journal-title":"Clin Microbiol Infect"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/IAI.73.2.778-783.2005","article-title":"Fu Y, Edwards JE Jr. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro","volume":"73","author":"A S Ibrahim","year":"2005","journal-title":"Infect Immun"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"M M Roden","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"e241663","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?","volume":"14","author":"S M Revannavar","year":"2021","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mmcr.2021.03.006","article-title":"Pulmonary aspergillosis and mucormycosis in a patient with COVID-19","volume":"32","author":"A K Johnson","year":"2021","journal-title":"Med Mycol Case Rep"},{"issue":"09","key":"ref17","first-page":"e10726","article-title":"Rhino-orbital mucormycosis associated with COVID-19","volume":"12","author":"S Mehta","year":"2020","journal-title":"Cureus"},{"issue":"11","key":"ref18","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3201\/eid2611.203504","article-title":"Multidrug-resistant Candida auris infections in critically Ill coronavirus disease patients, India, April-July 2020","volume":"26","author":"A Chowdhary","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s11046-020-00472-7","article-title":"Opportunistic fungal infections in the epidemic area of COVID-19: a clinical and diagnostic perspective from Iran","volume":"185","author":"M Salehi","year":"2020","journal-title":"Mycopathologia"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1097\/IOP.0000000000001889","article-title":"Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome","volume":"37","author":"Z K Mekonnen","year":"2021","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a viral land: a tale of two pathogens","volume":"69","author":"M Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.mycmed.2020.100971","article-title":"Invasive fungal diseases during COVID-19: We should be prepared","volume":"30","author":"J P Gangneux","year":"2020","journal-title":"J Mycol Med"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/CMR.00118-13","article-title":"Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion","volume":"27","author":"S J Dando","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"e02010","DOI":"10.1128\/mBio.02010-17","article-title":"Robust Phagocyte Recruitment Controls the Opportunistic Fungal Pathogen Mucor circinelloides in Innate Granulomas In Vivo","volume":"9","author":"S Inglesfield","year":"2018","journal-title":"MBio"},{"issue":"07","key":"ref25","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1515\/jpem-2020-0623","article-title":"Pulmonary and cutaneous mucormycosis in two children with diabetes mellitus type 1","volume":"34","author":"N Ghaemi","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mmcr.2021.03.005","article-title":"Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement","volume":"32","author":"R P Miller","year":"2021","journal-title":"Med Mycol Case Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01676830.2021.1903044","article-title":"Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19","author":"L O Dallalzadeh","year":"2021","journal-title":"Orbit"},{"issue":"01","key":"ref28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.14639\/0392-100X-N0848","article-title":"Definition and management of invasive fungal rhinosinusitis: a single-centre retrospective study","volume":"41","author":"G L Fadda","year":"2021","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"01","key":"ref29","doi-asserted-by":"publisher","first-page":"74. Doi","DOI":"10.1186\/s13613-020-00673-9","article-title":"Mucormycosis in intensive care unit: surgery is a major prognostic factor in patients with hematological malignancy","volume":"10","author":"J Claustre","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13000-021-01094-3","article-title":"Rhinocerebral mucormycosis secondary to severe acute pancreatitis and diabetic ketoacidosis: a case report","volume":"16","author":"J Wang","year":"2021","journal-title":"Diagn Pathol"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"101125","DOI":"10.1016\/j.mycmed.2021.101125","article-title":"Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature","volume":"31","author":"A Khatri","year":"2021","journal-title":"J Mycol Med"},{"issue":"07","key":"ref32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/myc.13283","article-title":"Frequency of occurrence, seasonal variation and antifungal susceptibility of opportunistic Mucorales isolated from hospital soils in Iran","volume":"64","author":"A Vaezi","year":"2021","journal-title":"Mycoses"},{"issue":"S 01","key":"ref33","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"T J Walsh","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"04","key":"ref34","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1128\/JCM.03102-13","article-title":"The value of postmortem microbiology cultures","volume":"52","author":"S Riedel","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"02","key":"ref35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.00053-10","article-title":"Histopathologic diagnosis of fungal infections in the 21st century","volume":"24","author":"J Guarner","year":"2011","journal-title":"Clin Microbiol Rev"},{"issue":"S 02","key":"ref36","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC\/MSGERC","volume":"72","author":"B D Alexander","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0028-1096209","article-title":"Imaging findings of rhinocerebral mucormycosis","volume":"19","author":"D A Herrera","year":"2009","journal-title":"Skull Base"},{"issue":"07","key":"ref38","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/microorganisms9071518","article-title":"Microbiological and Molecular Diagnosis of Mucormycosis: From Old to New","volume":"9","author":"N Lackner","year":"2021","journal-title":"Microorganisms"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.3389\/fmicb.2018.02923","article-title":"Liquid-Based Cytopathology Test: A Novel Method for Diagnosing Pulmonary Mucormycosis in Bronchial Brushing Samples","volume":"9","author":"X Jiang","year":"2018","journal-title":"Front Microbiol"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and Diagnosis of Mucormycosis: An Update","volume":"6","author":"A Skiada","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"09","key":"ref41","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40265-013-0069-4","article-title":"Amphotericin B formulations: a comparative review of efficacy and toxicity","volume":"73","author":"R J Hamill","year":"2013","journal-title":"Drugs"},{"issue":"07","key":"ref42","first-page":"e16152","article-title":"Coronavirus Disease-Associated Mucormycosis from a Tertiary Care Hospital in India: A Case Series","volume":"13","author":"Y Singh","year":"2021","journal-title":"Cureus"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"A K Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"06","key":"ref44","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4103\/ijo.IJO_310_21","article-title":"Rise of the phoenix: Mucormycosis in COVID-19 times","volume":"69","author":"S A Ravani","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"08","key":"ref45","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/S2213-2600(21)00265-4","article-title":"Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?","volume":"9","author":"A Raut","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"03","key":"ref46","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/jof4030090","article-title":"Therapy of Mucormycosis","volume":"4","author":"N V Sipsas","year":"2018","journal-title":"J Fungi (Basel)"},{"issue":"03","key":"ref47","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00003495-200969030-00010","article-title":"Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections","volume":"69","author":"M D Moen","year":"2009","journal-title":"Drugs"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1086\/376634","article-title":"Amphotericin B: time for a new \u201cgold standard\u201d","volume":"37","author":"L Ostrosky-Zeichner","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref49","first-page":"9","article-title":"Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients","volume":"5","author":"M H Miceli","year":"2012","journal-title":"Infect Drug Resist"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40272-020-00379-2","article-title":"Administration and Dosing of Systemic Antifungal Agents in Pediatric Patients","volume":"22","author":"K J Downes","year":"2020","journal-title":"Paediatr Drugs"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2165\/00023210-200721040-00004","article-title":"Fungal infections of the CNS: treatment strategies for the immunocompromised patient","volume":"21","author":"K E Black","year":"2007","journal-title":"CNS Drugs"},{"issue":"03","key":"ref52","first-page":"165","article-title":"Intravenous itraconazole vs. amphotericin B deoxycholate for empirical antifungal therapy in patients with persistent neutropenic fever","volume":"21","author":"S H Park","year":"2006","journal-title":"Korean J Intern Med (Korean Assoc Intern Med"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/08998280.2007.11928283","article-title":"Posaconazole (Noxafil): a new triazole antifungal agent","volume":"20","author":"N D Greer","year":"2007","journal-title":"Proc Bayl Univ Med Cent"},{"issue":"04","key":"ref54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1155\/2008\/825901","article-title":"Posaconazole: A new agent for the prevention and management of severe, refractory or invasive fungal infections","volume":"19","author":"A V Page","year":"2008","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"08","key":"ref55","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/21505594.2017.1368942","article-title":"Immune responses to Mucorales growth forms: Do we know everything?","volume":"8","author":"E Roilides","year":"2017","journal-title":"Virulence"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/599105","article-title":"Edwards J Jr, Ibrahim AS. Recent advances in the management of mucormycosis: from bench to bedside","volume":"48","author":"B Spellberg","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"20","key":"ref57","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1182\/blood-2011-07-366526","article-title":"Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients","volume":"118","author":"L Potenza","year":"2011","journal-title":"Blood"},{"issue":"03","key":"ref58","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/jof6030173","article-title":"Host Immune Defense upon Fungal Infections with Mucorales: Pathogen-Immune Cell Interactions as Drivers of Inflammatory Responses","volume":"6","author":"D E Monta\u00f1o","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"03","key":"ref59","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/jof3030048","article-title":"Innate and Adaptive Immunity to Mucorales","volume":"3","author":"H Ghuman","year":"2017","journal-title":"J Fungi (Basel)"},{"issue":"S 02","key":"ref60","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1093\/mmy\/myz011","article-title":"Pathogenicity patterns of mucormycosis: epidemiology, interaction with immune cells and virulence factors","volume":"57","author":"M IA Hassan","year":"2019","journal-title":"Med Mycol"},{"issue":"11","key":"ref61","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/JCM.01737-13","article-title":"\u03b2-D-glucan testing is important for diagnosis of invasive fungal infections","volume":"51","author":"E S Theel","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"03","key":"ref62","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jof2030022","article-title":"Galactomannan and 1,3-\u03b2-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis","volume":"2","author":"F Lamoth","year":"2016","journal-title":"J Fungi (Basel)"}],"container-title":["Avicenna Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1735383.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T18:49:42Z","timestamp":1638816582000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1735383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":61,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2021,12,6]]},"published-print":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1735383","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2231-0770","2249-4464"],"issn-type":[{"value":"2231-0770","type":"print"},{"value":"2249-4464","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}